$Unfractionated heparin reverses aspirin inhibition of platelets during coronary artery bypass graft surgery$

Unfractionated heparin reverses aspirin inhibition of platelets during coronary artery bypass graft surgery

Abstract Unfractionated heparin (UFH) is an effective antithrombotic during surgery but has known adverse effects, in particular on platelets. A marked increase in platelet responsiveness has previously been observed in patients within minutes of receiving UFH, despite adequate inhibition by aspirin...

Full description

Bibliographic Details
Main Authors:	Robert E. Turnbull, Azhar Hafeez, Katrin N. Sander, David A. Barrett, Gavin J. Murphy, Alison H. Goodall
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-04-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-024-58005-x

Similar Items

Successful combination therapy of low-dose aspirin and unfractionated heparin in recurrent pregnancy loss: A case report
by: Adhi Pribadi
Published: (2023-04-01)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
by: Flávio Luís Garcia, et al.
Published: (2015-08-01)

Effects of Bemiparin, Dalteparin, and Unfractionated Heparin on Platelet Interaction With Human Subendothelium Under Flow Conditions
by: Jose Antonio González-Correa, et al.
Published: (2008-01-01)

Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis
by: Ercan Akşit, et al.
Published: (2020-09-01)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
by: Joseph Lewis BA, et al.
Published: (2022-05-01)

Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin
by: Wesley E. Workman, et al.
Published: (2020-01-01)

Comparison of Two Nomograms of Unfractionated Heparin in Patients with Acute Coronary Syndrome
by: Moneyreh Modares Mosadegh, et al.
Published: (2013-02-01)

Comparison of Two Nomograms of Unfractionated Heparin in Patients with Acute Coronary Syndrome
by: Moneyreh Modares Mosadegh, et al.
Published: (2013-02-01)

Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
by: Craig D. Seaman, et al.
Published: (2020-11-01)

The toxicokinetic profile of Dex40-GTMAC3 - a novel polysaccharide candidate for reversal of unfractionated heparin.
by: Emilia eSokolowska, et al.
Published: (2016-03-01)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
by: Thompson David, et al.
Published: (2006-09-01)

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease
by: Milne Ruairidh, et al.
Published: (2001-10-01)

Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions.
by: Jing-Ning Huang, et al.
Published: (2014-01-01)

Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer Cells
by: Jan Moritz Ponert, et al.
Published: (2018-10-01)

Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach
by: Ahmad Abdel-Hafez, et al.
Published: (2022-09-01)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
by: Alpesh Amin, et al.
Published: (2023-06-01)

LMWHs have additional advantage over unfractionated heparin: no volume load
by: GP Koracevic
Published: (2009-10-01)

Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides.
by: Navin K Kapur, et al.
Published: (2012-01-01)

Nonclinical evaluation of novel cationically modified polysaccharide antidotes for unfractionated heparin.
by: Bartlomiej Kalaska, et al.
Published: (2015-01-01)

Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO
by: Alexander S. Streng, et al.
Published: (2020-10-01)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
by: Hind Harrak Lazrak, et al.
Published: (2017-06-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
by: Kayla Torppey, et al.
Published: (2023-10-01)

Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
by: Kyle H. Moore, et al.
Published: (2020-06-01)

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome
by: Corinne Frere, et al.
Published: (2019-01-01)

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
by: Gerber Jonathan, et al.
Published: (2005-04-01)

Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome
by: M Janghorbani, et al.
Published: (2013-09-01)

PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION
by: A. V. Syrov, et al.
Published: (2010-04-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
by: Hosein Vakili, et al.
Published: (2007-04-01)

Randomized, Blinded Trial Comparing Enoxaparin with Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention
by: Hosein Vakili, et al.
Published: (2007-07-01)

Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)

Management of therapeutic unfractionated heparin in COVID‐19 patients: A retrospective cohort study
by: Lachelle D. Weeks, et al.
Published: (2021-05-01)

Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report
by: Aslan Efendizade, et al.
Published: (2020-09-01)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01)

Low molecular weight heparin versus Unfractionated heparin in patients with non ST-elevation acute coronary syndrome: a randomaized clinical trial
by: Zand parsa A, et al.
Published: (2007-09-01)

The evaluations of frequency distribution heparin resistance during coronary artery bypass graft
by: Kaivan Bagheri, et al.
Published: (2014-01-01)

Off-pump coronary artery bypass grafting using continuous heparin infusion
by: Kamales Kumar Saha, et al.
Published: (2016-11-01)

Immunological effects of anti-coagulant unfractionated heparin in pregnant Chinese women with cryptic recurrent miscarriages
by: Yanli Hong, et al.
Published: (2020-06-01)

Effects of Low Molecular Weight and Unfractionated Heparin on Lipoprotein Lipase and Lipid Profile in haemodialysis patients
by: Ahmad Jan, et al.
Published: (2021-06-01)

Renal unit practitioners’ knowledge, attitudes and practice regarding the safety of unfractionated heparin for chronic haemodialysis
by: Debra Ockhuis, et al.
Published: (2015-09-01)

Left Atrial Thrombus Resolution Using Unfractionated Heparin and Warfarin in a Patient with Mitral Stenosis
by: Zainuddin Zainuddin, et al.
Published: (2019-09-01)